PT971735E - Métodos e composições para tratamento de doença inflamatória do intestino - Google Patents

Métodos e composições para tratamento de doença inflamatória do intestino Download PDF

Info

Publication number
PT971735E
PT971735E PT98912149T PT98912149T PT971735E PT 971735 E PT971735 E PT 971735E PT 98912149 T PT98912149 T PT 98912149T PT 98912149 T PT98912149 T PT 98912149T PT 971735 E PT971735 E PT 971735E
Authority
PT
Portugal
Prior art keywords
compositions
methods
inflammatory bowel
bowel disease
treating inflammatory
Prior art date
Application number
PT98912149T
Other languages
English (en)
Portuguese (pt)
Inventor
Thomas Julius Borody
Original Assignee
Borody Thomas J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPO5940A external-priority patent/AUPO594097A0/en
Priority claimed from AUPO9785A external-priority patent/AUPO978597A0/en
Application filed by Borody Thomas J filed Critical Borody Thomas J
Publication of PT971735E publication Critical patent/PT971735E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT98912149T 1997-04-01 1998-04-01 Métodos e composições para tratamento de doença inflamatória do intestino PT971735E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO5940A AUPO594097A0 (en) 1997-04-01 1997-04-01 Novel methods of treating inflammatory bowel disease
AUPO9785A AUPO978597A0 (en) 1997-10-14 1997-10-14 Methods of treating inflammatory bowel disease

Publications (1)

Publication Number Publication Date
PT971735E true PT971735E (pt) 2008-06-02

Family

ID=25645389

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98912149T PT971735E (pt) 1997-04-01 1998-04-01 Métodos e composições para tratamento de doença inflamatória do intestino

Country Status (16)

Country Link
US (1) US6277836B1 (cg-RX-API-DMAC7.html)
EP (1) EP0971735B1 (cg-RX-API-DMAC7.html)
JP (3) JP2001524951A (cg-RX-API-DMAC7.html)
AR (1) AR012304A1 (cg-RX-API-DMAC7.html)
AT (1) ATE389417T1 (cg-RX-API-DMAC7.html)
CA (1) CA2285923C (cg-RX-API-DMAC7.html)
CY (1) CY1109783T1 (cg-RX-API-DMAC7.html)
DE (1) DE69839261T2 (cg-RX-API-DMAC7.html)
DK (1) DK0971735T3 (cg-RX-API-DMAC7.html)
ES (1) ES2303351T3 (cg-RX-API-DMAC7.html)
IL (1) IL132145A (cg-RX-API-DMAC7.html)
NO (1) NO325947B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ500696A (cg-RX-API-DMAC7.html)
PT (1) PT971735E (cg-RX-API-DMAC7.html)
SI (1) SI0971735T1 (cg-RX-API-DMAC7.html)
WO (1) WO1998043667A1 (cg-RX-API-DMAC7.html)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551632B2 (en) * 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
AUPP325398A0 (en) 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
JP2002536404A (ja) * 1999-02-12 2002-10-29 ワシントン ユニバーシティー 炎症性腸疾患を治療するための好中球機能の刺激
UY26380A1 (es) 1999-10-08 2001-04-30 Smithkline Beecham Corp Inhibidores de fab i
JP3369535B2 (ja) 1999-11-09 2003-01-20 松下電器産業株式会社 プラズマディスプレイ装置
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
HRP20020781A2 (en) * 2000-03-28 2004-12-31 Biochemie Gmbh Granulated particles with masked taste
CA2495537C (en) * 2000-08-29 2010-03-30 Nobex Corporation Immunoregulatory compounds and derivatives and methods of treating diseases therewith
AU2002367773A1 (en) * 2001-04-06 2003-11-03 Affinium Pharmaceuticals, Inc. Fab i inhibitors
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US20030118329A1 (en) * 2001-12-21 2003-06-26 Pere Obrador Video indexing using high resolution still images
AUPS088702A0 (en) * 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
JP4880448B2 (ja) 2003-03-17 2012-02-22 アフィナム ファーマシューティカルズ，インコーポレーテッド 複数の抗生物質を含む組成物、及びそれを用いる方法
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
WO2005046567A2 (en) * 2003-09-10 2005-05-26 Meena Shelgaonkar Synergistic formulation of antioxidants and antimycobacterial agents: a method of making the same
CA2553775A1 (en) 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
NZ549661A (en) 2004-02-06 2010-07-30 Pharmatel R & D Pty Ltd As Tru Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome
DE602005022175D1 (de) * 2004-05-28 2010-08-19 Salix Pharmaceuticals Inc Prävention, behandlung und linderung strahlungsinduzierter enteritis
KR101299399B1 (ko) * 2004-06-04 2013-08-22 아피늄 파마슈티컬스, 인크. 치료제, 및 그의 제조 및 사용 방법
EP1773767B1 (en) 2004-07-07 2016-03-09 Biocon Limited Synthesis of azo bonded immunoregulatory compounds
NZ593132A (en) * 2005-08-24 2013-02-22 Salix Pharmaceuticals Ltd Balsalazide formulations and manufacture and use thereof
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
CA2531261A1 (en) * 2005-12-21 2007-06-21 Institut Pasteur Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria
JP5468899B2 (ja) 2006-07-20 2014-04-09 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉインヒビターとしてのアクリルアミド誘導体
EP2125802A4 (en) 2007-02-16 2014-08-20 Debiopharm Int Sa SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS
US7541384B2 (en) 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
JP2011500552A (ja) * 2007-10-10 2011-01-06 ルピン・リミテッド 胃腸障害を処置するための医薬用組み合わせおよび組成物
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions
US20090131343A1 (en) * 2007-11-15 2009-05-21 Ly Tam Phan Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases
ES2708087T3 (es) 2008-02-08 2019-04-08 Red Hill Biopharma Ltd Procedimientos y composiciones para tratar enfermedad inflamatoria intestinal
CN102014926A (zh) * 2008-05-01 2011-04-13 宝洁公司 用于治疗炎性肠病的方法和试剂盒
US20110082120A1 (en) * 2009-10-05 2011-04-07 Milne Jill C Substituted thioacetic acid salicylate derivatives and their uses
PL2493471T3 (pl) 2009-10-26 2020-10-19 Borody Nowa skojarzona terapia jelitowa
AU2011245455A1 (en) 2010-04-26 2012-11-15 Salix Pharmaceuticals, Ltd. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
NZ611868A (en) 2010-12-13 2015-11-27 Salix Pharmaceuticals Inc Gastric and colonic formulations and methods for making and using them
TWI573590B (zh) * 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
ES2717282T3 (es) 2012-07-27 2019-06-20 Redhill Biopharma Ltd Formulaciones y métodos para fabricar formulaciones para su uso en la evacuación colónica
EP3145510B8 (en) * 2014-05-22 2021-10-27 Kuenstner, John, Todd Treatment of diseases using combination of ultraviolet blood irradiation and antibiotics
US10751351B2 (en) 2016-02-26 2020-08-25 Debiopharm International S.A. Medicament for treatment of diabetic foot infections
LT3923914T (lt) 2019-02-14 2023-07-25 Debiopharm International S.A. Afabicino kompozicija, jos gamybos būdas
US12414958B2 (en) 2019-06-14 2025-09-16 Debiopharm International S.A. Medicament and use thereof for treating bacterial infections involving biofilm
MX2023000165A (es) 2020-06-30 2023-02-22 Redhill Biopharma Ltd Productos de combinacion de dosis fijas de tres antibioticos, regimen de dosificacion, metodos y kits para tratar infecciones micobacterianas pulmonares no tuberculosas.
WO2025026423A1 (en) * 2023-08-02 2025-02-06 Shenzhen Pharmacin Co., Ltd. Compositions, their use and manufacture for treatment of gastrointestinal conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions

Also Published As

Publication number Publication date
JP2012126736A (ja) 2012-07-05
NO994778D0 (no) 1999-09-30
ES2303351T3 (es) 2008-08-01
EP0971735A4 (en) 2004-02-25
NO994778L (no) 1999-11-30
JP2008024713A (ja) 2008-02-07
AR012304A1 (es) 2000-10-18
EP0971735B1 (en) 2008-03-19
DE69839261D1 (de) 2008-04-30
IL132145A (en) 2005-11-20
DK0971735T3 (da) 2008-07-07
DE69839261T2 (de) 2009-03-26
SI0971735T1 (sl) 2008-08-31
CA2285923A1 (en) 1998-10-08
US6277836B1 (en) 2001-08-21
WO1998043667A1 (en) 1998-10-08
EP0971735A1 (en) 2000-01-19
CY1109783T1 (el) 2013-09-04
IL132145A0 (en) 2001-03-19
NO325947B1 (no) 2008-08-25
CA2285923C (en) 2013-03-12
ATE389417T1 (de) 2008-04-15
NZ500696A (en) 2002-05-31
JP2001524951A (ja) 2001-12-04

Similar Documents

Publication Publication Date Title
IL132145A0 (en) Methods and compositions for treating inflammatory bowel disease
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
IL142132A0 (en) Methods and compositions for treating receptor mediated diseases
HUP0201436A3 (en) Methods and compositions for treating solid tumors
GR20010300060T1 (en) Methods and compositions for treating and preventing mucositis
GB9709522D0 (en) Early Entry PCT
AU9214398A (en) Compositions and methods for treating water
IL132758A0 (en) Methods for treating inflammation and inflammatory diseases using padprt
AU1917201A (en) Amide therapeutics and methods for treating inflammatory bowel disease
AU2327599A (en) Compositions and methods for treating autoimmune diseases
PL332415A1 (en) Ore cleaning compositions and methods
PL336349A1 (en) Compositions for and methods for treating and diagnosing the mastocarcinoma
EP1056456A4 (en) R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
EP1056457A4 (en) S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
GB9624501D0 (en) Insecticial compositions and method
EP1073333A4 (en) S-RABEPRAZOL COMPOSITIONS AND METHODS
IL141047A0 (en) Methods and compositions for treating gastro-esophageal reflux disease
HUP0203152A3 (en) Method and compositions for treating pulmonary diseases
IL150963A0 (en) Method and compositions for treating an inflammatory disease
ZA9710934B (en) Compositions and methods for administering pneumococal dna
IL120488A (en) Modifiers for water-setting inorganic compositions and modified water-setting inorganic compositions
GB2286775B (en) Reticular or net like condom for men
ZA982645B (en) Methods and compositions for treating inflammatory bowel disease
EP1073332A4 (en) R-RABEPRAZOL COMPOSITIONS AND METHODS